SurfWax News Index  |  Track News  |  Save/Exchange Information |  About Us

    News and Articles on Acellular



    Whooping Cough Immunity Lasts 30 Years or More  Nov 3, 2009
    "The data we're using are from a time when a whole-cell vaccine was in use. Now an acellular vaccine, which stimulates a different part of the immune system, is typically used, especially in North America.". SOURCE: Public Library of Science, news release, Oct. 29, 2009. (MEDLINEplus)

    State changes school immunization requirements for school year  Aug 7, 2009
    Tetanus, diphtheria, acellular pertussis-containing vaccine (Tdap). All students entering seventh grade are required have had one dose of Tdap vaccine. (McKinney Courier-Gazette, TX)

    Children required to take new vaccines  Jun 4, 2009
    Students entering the 7th grade must have the tetanus, diphtheria, acellular pertussis-containing vaccine if they ve not had the booster within the last five years. Students entering grades 8 - 12 must have the booster shot if they have not had one in the last 10 years. (San Antonio Business Journal, TX)

    New immunization requirements for 2009-10 school year finalized  Mar 28, 2009
    Tetanus, Diphtheria and acellular pertussis-containing vaccine (Tdap): Beginning Aug. 1, 2009, all students entering the seventh grade will be required to have one dose of Tdap vaccine. Students in the seventh grade will be required to have a booster dose of Tdap only if it has been five years since their last dose of a tetanus-containing vaccine. (Cedar Park Hill Country News Weekender, TX)

    Eleven cases of Whooping Cough reported here, most in high school.  Feb 12, 2009
    "All persons 11 through 18 years of age should have a Tdap (tetanus, diphtheria, acellular pertussis) vaccination. Those who have not had that booster should get it.". The ten-year average of pertussis cases in the four counties of the Central District Health Department is about 30 cases per year. (Mountain Home News)

    Combination Vaccine Safe and Effective For Infants  Feb 7, 2009
    The randomized trial was conducted to support U.S. licensure of the vaccine known as DTaP5-IPV-Hib, which incorporates diphtheria-tetanus-5-component acellular pertussis (DTaP5), inactivated poliovirus (IPV), and Haemophilus influenzae type B (Hib) vaccines. Nearly 2000 infants were vaccinated at 2, 4, and 6 months of age, either with the DTaP5-IPV-Hib combination vaccine (Pentacel; Sanofi Pasteur Ltd., Toronto, Ontario) or with the DTaP5, IPV and Hib vaccines administered separately. (MEDLINEplus)




    Back to Health News

[ Terms Of Use | Privacy | About ]
©1998-2009 SurfWax, Inc.
All rights reserved. Patents pending.



Copyright SurfWax, Inc. 2009